https://redicareokemos.com/ https://grandriverfamilycare.com/

Oversees the Office of Medical Affairs for MI Medicaid Programs• Policy Review• Pharmacy Review Division• Pharmacy Prior Authorization• MIHealth Link (Dual Eligible Medicaid/Medicare Program)• Peer Review with MPRO• Certificate of Need (CON) Reviews • Transplantation Services• Quality Metrics

• Pharmacy Review Division• Pharmacy Prior Authorization• MIHealth Link (Dual Eligible Medicaid/Medicare Program)• Peer Review with MPRO• Certificate of Need (CON) Reviews • Transplantation Services• Quality Metrics• Policy Review

• Chair, US Cardiovascular Medical Affairs Teams for lipids and thrombosis• Responsible for the US medical affairs strategy and tactical plan and lead architect for the global and US medical affairs plans for ezetimibe, anacetrapib, vorapaxar and previously Tredaptive• (Co)responsible for developing the global scientific platform • Voting member – Global Scientific Affairs Team• Voting member – Product Development Team• Chair US Advisory Boards and co-planner for global advisory boards• Plan US and Co-plan Global Expert Input forums • Co-coordinate Medical Affairs Activities at Global and US Professional Society Meetings• Co-coordinate the US and global publications plan• Co-lead the global and US medical education plan• Co-lead product dossier development• Past Chair and Presently Co-chair Investigator Initiated Studies Program (IISP) • Manage a Physician Scientific Leadership Network with 300 global cardiovascular academic and scientific leaders • Lead Academic Liaison Activities (with the CSL Team) – 60 Medical Schools in 35 states (focus on Cardiometabolic Disorders & Lipids)• Provide Phase III and IV Clinical Studies Support (site management, IRB reviews, trial design, market development strategies)• Assist in Clinical Research Site Network Development (identify new clinical research sites within North America)• Facilitate Outcomes Research activities – conduct appropriate observational studies to help optimize patient adherence and therapeutic goal achievement including data safety and monitoring• Identify new and emerging external scientific discoveries refer opportunities inward for both preclinical and clinical areas in the cardio-metabolic therapeutic areas

• Managed Care Support – QI and Disease Management Support for 30 MCO’s• Consultant RMD – National & Regional Disease Management Programs (Stroke, MI, Dyslipidemia, Diabetes and CAD, Women's Health, Asthma, & Migraine)• National Point RMD – Medicaid & Government Affairs• Franchise Regional Support – Atherosclerosis, Hypertension, Stroke, Asthma, Osteoporosis, Migraine, Oncology, and Arthritis• Field Liaison – Merck USHH Medical & Scientific Affairs (MEDSA)• Field Liaison – Merck Research Labs and Clinical Development Program• National Point RMD – Oncology Franchise• National Point RMD – web-based initiatives team• Regional Point RMD – Cardiovascular and Diabetes Franchises• Co-national Point RMD – Depression Franchise• Regional Point RMD – Migraine Franchise• Regional Point RMD – Pain and Joint Disease Franchise• Field Liaison – 19 Midwest Medical Schools in eight states